Matthew Sorrentino to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Matthew Sorrentino has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.216
-
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial. Lancet Neurol. 2025 Apr; 24(4):295-304.
Score: 0.171
-
The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol. 2005 Oct 10; 104(3):264-8.
Score: 0.044